Skip to main content

Collegium Pharmaceutical, Inc

COLL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001267565

No open-market purchases or sales by Collegium Pharmaceutical, Inc insiders were filed in the last 90 days; 279 institutions reported holding it in 13F filings for Q2 2026, worth $1.42B in total; no superinvestor holds it.

13F holders, Q4 2023

Institutional positions in Collegium Pharmaceutical, Inc as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
193
+19 vs. Q3 2023
Shares held
39.2M
+573.1K (+1.5%) vs. Q3 2023
Total value
$1.21B
+$342.1M (+39.5%) vs. Q3 2023
New holders
32
58 more added
Sold out
13
77 more reduced

1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting COLL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2023: 193 institutions
Q1 2021: 163 institutionsQ2 2021: 159 institutionsQ3 2021: 155 institutionsQ4 2021: 159 institutionsQ1 2022: 172 institutionsQ2 2022: 157 institutionsQ3 2022: 169 institutionsQ4 2022: 179 institutionsQ1 2023: 199 institutionsQ2 2023: 178 institutionsQ3 2023: 175 institutionsQ4 2023: 193 institutionsQ1 2024: 228 institutionsQ2 2024: 229 institutionsQ3 2024: 249 institutionsQ4 2024: 238 institutionsQ1 2025: 241 institutionsQ2 2025: 223 institutionsQ3 2025: 243 institutionsQ4 2025: 279 institutionsQ1 2026: 267 institutionsQ2 2026: 279 institutions
Value heldQ4 2023: $1.21B
Q1 2021: $900.7MQ2 2021: $898.3MQ3 2021: $719.5MQ4 2021: $669.4MQ1 2022: $733.9MQ2 2022: $645.5MQ3 2022: $574.6MQ4 2022: $837.7MQ1 2023: $936.9MQ2 2023: $843.5MQ3 2023: $865.2MQ4 2023: $1.21BQ1 2024: $1.54BQ2 2024: $1.28BQ3 2024: $1.49BQ4 2024: $1.06BQ1 2025: $1.10BQ2 2025: $1.06BQ3 2025: $1.29BQ4 2025: $1.72BQ1 2026: $1.26BQ2 2026: $1.42B
Institutions holding COLL and their total value by quarter
QuarterHoldersValue
Q2 2026279$1.42B
Q1 2026267$1.26B
Q4 2025279$1.72B
Q3 2025243$1.29B
Q2 2025223$1.06B
Q1 2025241$1.10B
Q4 2024238$1.06B
Q3 2024249$1.49B
Q2 2024229$1.28B
Q1 2024228$1.54B
Q4 2023193$1.21B
Q3 2023175$865.2M
Q2 2023178$843.5M
Q1 2023199$936.9M
Q4 2022179$837.7M
Q3 2022169$574.6M
Q2 2022157$645.5M
Q1 2022172$733.9M
Q4 2021159$669.4M
Q3 2021155$719.5M
Q2 2021159$898.3M
Q1 2021163$900.7M

Institutions, Q4 2023

Shares, value and share of portfolio for each institution holding Collegium Pharmaceutical, Inc; share changes are against Q3 2023.

Institutions holding COLL in Q4 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Campbell & CO Investment Adviser LLC0$00.00%−12,871−100.0%Sold out
Institute for Wealth Management, LLC.0$00.00%−12,606−100.0%Sold out
Point72 Middle East FZE0$00.00%−9,142−100.0%Sold out
Group One Trading, L.P.0$00.00%−1,888−100.0%Sold out
Point72 Asset Management, L.P.0$00.00%−952−100.0%Sold out
Newbridge Financial Services Group, Inc.0$00.00%−64−100.0%Sold out
Steward Financial Group LLC––––Not filed